011040 — Kyungdong Pharm Balance Sheet
0.000.00%
- KR₩187bn
- KR₩203bn
- KR₩163bn
- 57
- 59
- 75
- 75
Annual balance sheet for Kyungdong Pharm, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 95,007 | 61,348 | 50,043 | 45,128 | 32,075 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 20,241 | 18,643 | 21,508 | 25,485 | 20,664 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 142,312 | 109,755 | 103,208 | 102,981 | 89,749 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 66,513 | 88,585 | 89,880 | 95,097 | 73,646 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 287,589 | 291,394 | 291,974 | 310,478 | 292,971 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 23,148 | 25,999 | 25,364 | 50,127 | 59,027 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 60,883 | 29,207 | 32,153 | 53,274 | 64,792 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 226,706 | 262,187 | 259,821 | 257,204 | 228,179 |
Total Liabilities & Shareholders' Equity | 287,589 | 291,394 | 291,974 | 310,478 | 292,971 |
Total Common Shares Outstanding |